Natural vs. Synthetics: Why We Are Betting on the Natural World

Have you ever felt like something is off with modern medicine?

Modern medicine can replace joints, transplant organs, open blocked arteries, and keep critically ill patients alive. Pharmaceutical companies can isolate molecules, manipulate biological pathways, and manufacture drugs at a massive scale.

Yet Americans are not becoming healthier overall. Obesity has exploded. Diabetes is widespread. Chronic illness affects most families. Millions of people take multiple prescriptions every day. More intervention has created more dependence on intervention.

The human body was not designed in a pharmaceutical laboratory. Human biology developed in constant contact with soil, plants, sunlight, minerals, microbes, water, and natural cycles. Health does not begin with a diagnosis or prescription. It begins with food, movement, sleep, sunlight, minerals, environmental exposure, and the conditions in which people live.

American medicine became centralized, laboratory-driven, and increasingly dependent on patentable products during the twentieth century. The Flexner-Rockefeller transformation helped push natural healing outside the medical mainstream and laid the institutional foundation for the treatment-heavy sick-care system operating today.

The Flexner Report Changed American Medicine

In 1910, the Carnegie Foundation published Abraham Flexner’s Medical Education in the United States and Canada. Flexner inspected 155 medical schools and reported major inconsistencies in admission standards, laboratories, curricula, and clinical training.

Some reform was justified. Fraud existed. Poorly trained practitioners existed. Products were sold without adequate testing or honest labeling. Medical education needed standards.

But Flexner did more than recommend better education. His report elevated one medical philosophy above its competitors. The approved model centered on university-controlled schools, laboratories, hospital training, chemistry, pathology, and experimental research. Homeopathy, naturopathy, eclectic medicine, chiropractic, osteopathy, and other approaches were broadly treated as unscientific.

The consequences were enormous. Medical schools closed. Alternative institutions lost credibility and financial support. Within roughly 20 years, the number of medical schools fell from 131 to 76. Schools training women and Black physicians were disproportionately damaged.

The report helped establish the boundaries of acceptable medicine. Once those boundaries were reinforced through licensing, accreditation, university funding, textbooks, and professional organizations, competing approaches could be dismissed before their individual methods were evaluated fairly.

This is where the word quackery became so powerful.

Calling a fraudulent salesman a quack is one thing. Using the same label against entire fields of natural practice is something else. It allows institutions to place contaminated remedies, dishonest advertising, herbs, nutritional approaches, traditional medicine, and homeopathy into one condemned category.

The public was not simply taught to demand evidence. It was taught which institutions were permitted to define evidence.

What Rockefeller Actually Controlled

John D. Rockefeller controlled Standard Oil and accumulated one of the largest fortunes in history. His wealth came from petroleum. His philanthropic organizations later invested heavily in universities, medical schools, laboratories, research institutions, and public-health programs.

The Carnegie Foundation commissioned the Flexner Report. Rockefeller did not personally write it. But Rockefeller money helped build the system Flexner recommended. That distinction does not erase the result.

Money decides which institutions expand. Money builds laboratories. Money funds research. Money supports approved textbooks and curricula. Money creates professional careers. Money also determines which ideas remain underfunded, understudied, and outside the gates.

Schools that could afford laboratories, university affiliations, and teaching hospitals were positioned to survive. Smaller homeopathic, eclectic, and nature-oriented schools were not. Rockefeller’s General Education Board directed millions of dollars toward institutions that adopted the emerging biomedical model.

This was a turning point. American medicine stopped being an open contest between different approaches and became a controlled institutional system.

Rockefeller controlled oil. Oil wealth financed part of the medical transformation. Petrochemistry became central to modern industry and pharmaceutical manufacturing. Meanwhile, natural approaches were increasingly described as backward, dangerous, or fraudulent.

Was every natural practitioner right? No. Was every laboratory dishonest? No. That is not the point.

The point is that one concentrated financial network helped determine what would be taught, funded, licensed, published, and recognized as legitimate. Natural medicine was difficult to centralize because people could grow plants, preserve community knowledge, and use inexpensive substances outside a proprietary supply chain. Standardized commercial products were easier to manufacture, regulate, own, distribute, and monetize.

The historical record documents the money, institutional funding, school closures, and rise of laboratory medicine. These forces did more than improve medical education. They helped demonize the natural world and replace decentralized healing with an intervention system controlled by institutions.

Propaganda does not always arrive as an obvious lie. It can operate through selective funding, repeated terminology, approved experts, rewritten curricula, professional exclusion, and the disappearance of competing ideas. Repeat one worldview for several generations and people eventually mistake it for the only worldview that ever existed.

Natural and Synthetic Are Not Opposites

Nature has always been one of humanity’s greatest chemical libraries.

Aspirin was inspired by salicylate chemistry associated with willow. Morphine came from the opium poppy. Digoxin came from foxglove. Artemisinin came from sweet wormwood. Paclitaxel came from the Pacific yew. Antibiotic discovery was transformed by substances produced by microorganisms.

Even pharmaceutical research repeatedly returns to nature for molecular templates. Reviews of approved medicines have found that a substantial portion are natural products, derivatives of natural products, or synthetic compounds modeled after natural structures.

The pharmaceutical industry frequently takes knowledge or chemistry found in nature, isolates an active compound, alters it, standardizes it, patents a product around it, and then sells it back to the public through a controlled medical system.

Natural and synthetic chemistry are not always cleanly separated:

• A natural product comes directly from a plant, fungus, bacterium, mineral, or other natural source.
• A nature-derived medicine begins with natural chemistry but may be purified or modified.
• A synthetic drug is manufactured through chemical processes, although its structure may imitate nature.
• A biologic is produced through living cells and includes products such as antibodies.

Natural does not automatically mean harmless. Hemlock is natural. Ricin is natural. Botanical extracts can interact with medications or cause harm at inappropriate doses.

But this truth is often used selectively. Institutions warn people that herbs contain powerful chemicals while pretending that this power somehow makes laboratory chemicals more trustworthy. The existence of natural risk does not justify dismissing natural medicine. It justifies honest education, accurate labeling, contaminant testing, proper dosing, and serious research.

The question is not whether a substance is natural or synthetic by itself. The questions are who controls it, how it is processed, what dose is used, what evidence exists, what risks are hidden, and whether the treatment supports health or creates permanent dependence.

The current system has created dependence on drugs purposefully for profit. We have lost our moral ground and most Dr’s are now pharmaceutical drug pushers, not healers. We must get back to the natural world and to the root cause of problems.

How Drug Development Can Look Like “Mad Science”

Modern drug development can sound like science fiction because much of it is.

Researchers select a biological target, screen large chemical libraries, alter molecular structures, grow engineered cells, manipulate animals, test escalating doses, measure organ damage, and eliminate compounds that fail toxicity standards. The surviving candidates move toward human trials.

Animals may be restrained, injected, surgically altered, deliberately made ill, exposed during pregnancy, or killed so researchers can examine their organs. These experiments can study toxicity, cancer risk, reproductive harm, genetic damage, metabolism, and the dose at which serious injury occurs.

There are two problems. The first is ethical. Animals experience pain and distress for products that may later fail or provide little meaningful benefit.

The second is scientific. A mouse is not a human. A dog is not a human. Animal metabolism, immune function, lifespan, and disease models do not perfectly reproduce human biology. A drug that appears safe in animals can harm people. A compound that fails in animals could potentially behave differently in humans.

Newer systems, human-cell models, organoids, organs on chips, computational toxicology, and other human-relevant technologies, should receive far more investment. If the pharmaceutical industry calls itself advanced, it should lead the transition away from crude animal models instead of defending them indefinitely.

Safety testing is necessary. The question is whether the system uses the most accurate, humane, and transparent science available, or simply continues the methods around which its institutions were built.

Clinical Trials and the Placebo Effect

Human clinical trials are presented as the final authority. In theory, they determine whether a drug is safe and effective. In practice, the result depends heavily on how the trial is designed, whom it includes, what it measures, how long it lasts, and how the numbers are presented.

Randomization attempts to distribute differences between groups. Blinding reduces the influence of expectations. Placebos help distinguish the drug’s specific effect from expectation, attention, natural symptom fluctuation, and other changes that occur during a study.

The placebo effect is real. That does not mean illness is imaginary. Pain, nausea, anxiety, fatigue, and perceived function can change through expectation, conditioning, the clinical environment, and the body’s own response systems.

This should make medicine more interested in the mind-body connection. Instead, placebo response is usually treated as statistical noise that must be subtracted before a proprietary product can receive credit.

Trials also contain vulnerabilities:

• Participants may be healthier or less medically complicated than real patients.
• A short trial may miss delayed injury.
• A surrogate marker may improve without producing a meaningful health benefit.
• A statistically significant result may be clinically small.
• Negative trials may receive less attention than positive trials.
• Sponsors can influence design, analysis, publication, and marketing.
• Rare side effects may appear only after millions of people use a product.

Relative risk is another marketing weapon. A company can advertise a 50% reduction when an outcome falls from two people in 1,000 to one person in 1,000. The relative reduction is 50%, but the absolute reduction is only one-tenth of one percentage point.

Patients deserve both numbers. They deserve meaningful endpoints, complete adverse-event reporting, adequate follow-up, independent replication, and access to negative results.

The problem is not that trials exist. The problem is that the industry paying for the trial may also design it, control the data, interpret the outcome, and market the product.

Why Side-Effect Lists Become So Long

A synthetic drug does not enter one isolated part of the body. It enters an interconnected biological system.

A molecule designed for one receptor, enzyme, hormone, immune signal, or metabolic pathway may affect multiple organs. The liver transforms drugs into metabolites. The kidneys remove them. Genetics, age, diet, alcohol, supplements, hydration, mineral status, and other prescriptions can change how the body responds.

That is why side-effect lists become so long.

One medication can create a symptom that leads to another diagnosis. A second medication may be prescribed to control that symptom. The second drug creates another problem, and a third product is added. This is known as a prescribing cascade.

The patient may eventually be taking five, ten, or more medications, with no single practitioner stepping back to ask whether the original problem could have been addressed through nutrition, minerals, sleep, movement, weight loss, sunlight, toxin reduction, or deprescribing.

A long drug label does not prove that every user will experience every side effect. Disclosure is necessary. But informed consent should mean more than handing someone a folded insert filled with technical language.

Patients should be told the absolute probability of benefit and harm, how long the drug was studied, what it was compared against, what happens when treatment stops, whether non-drug approaches were compared, and how many people must take it for one person to benefit.

The Honest Health Chart

Statistics can be manipulated by choosing the wrong measurement.

Raw death counts rise when a population becomes larger and older. Age-adjusted mortality provides a fairer historical comparison. By that measurement, American mortality declined significantly during the twentieth century. Life expectancy also increased.

That does not mean Americans became metabolically healthier.

Among U.S. adults ages 20–74, age-adjusted obesity prevalence increased from 13.4% in 1960–1962 to 40.8% in August 2021–August 2023. Severe obesity rose from 0.9% to 10.2%. The CDC estimates that diabetes affected 12% of the U.S. population in 2023.

Measure	Earlier figure	Recent figure	What it shows
Adult obesity, ages 20–74, age-adjusted	13.4% in 1960–1962	40.8% in 2021–2023	A major deterioration in metabolic health
Severe obesity, ages 20–74, age-adjusted	0.9% in 1960–1962	10.2% in 2021–2023	More than a tenfold increase
Total diabetes, entire U.S. population	n/a	12.0% in 2023	Roughly 40.1 million people
U.S. age-adjusted all-cause death rate	715.2 per 100,000 in 2019	750.5 in 2023	Improvement from the pandemic peak, but still above 2019
U.S. life expectancy at birth	76.8 years in 2000	78.4 years in 2023	Longer survival does not measure freedom from chronic illness

These facts can exist together. People can live longer while spending more years obese, diabetic, medicated, disabled, or dependent on procedures.

Surgery is a perfect example. It is remarkable that surgeons can bypass blocked arteries and give someone additional years of life. But progress should also mean fewer people developing the metabolic and cardiovascular conditions that lead to surgery.

More advanced should eventually mean less intervention, not simply more sophisticated intervention.

Surgical volume alone cannot prove declining health because the population is older, diagnosis has improved, and previously impossible procedures are now available. But a health system should measure preventable disease, medication burden, healthy years, avoidable procedures, and quality of life, not only survival.

Should Drug Patents Be Illegal?

Society needs to reconsider whether lifesaving medicine should be controlled through private monopolies.

Patents can produce high prices, restricted access, delayed competition, product evergreening, and a financial preference for profitable long-term management over prevention. They also direct research money toward compounds that can be owned while inexpensive natural substances remain understudied.

Eliminating every pharmaceutical patent overnight without replacing the research-funding model could disrupt development. Clinical trials, manufacturing, quality systems, and toxicology require resources. That does not mean the current monopoly model is the only answer.

A serious replacement could include:

• Publicly funded drug development with open licensing
• Large prizes for verified clinical breakthroughs
• Milestone payments tied to meaningful patient outcomes
• Fair-pricing requirements whenever taxpayers funded the research
• Prohibitions against patenting naturally occurring molecules as they exist in nature
• Higher standards for secondary patents and minor formulation changes
• Faster generic and biosimilar competition
• Full public access to protocols, results, adverse events, and negative findings
• Independent trials comparing new drugs with the best existing treatment

The public should not fund foundational research, grant a monopoly, assume much of the risk, and then be charged whatever the patent holder believes the market will tolerate.

Medicine should reward genuine breakthroughs. It should not reward ownership games.

What a Health System Built for Health Would Do

A real health system would not eliminate trauma care, antibiotics, anesthesia, insulin, or surgery. It would put those tools in their proper place.

It would stop pretending rescue medicine is the same as health.

A health system built for health would:

• Treat food quality as medical policy
• Address minerals, movement, sunlight, sleep, stress, and metabolic function
• Reduce unnecessary exposure to environmental contaminants
• Study herbs and natural compounds without assuming they are inferior
• Research whole botanical preparations as well as isolated molecules
• Require identity, potency, and contaminant testing for natural products
• Teach physicians more nutrition, prevention, and deprescribing
• Compare patented drugs with lifestyle and nutritional interventions when appropriate
• Measure healthspan, medication burden, preventable procedures, and quality of life
• Separate medical education from commercial influence
• Make trial data and financial conflicts transparent
• Give patients honest benefit, risk, cost, and non-drug comparisons

The system should ask why a person became ill before deciding how to manage the illness forever.

Why We Are Betting on the Natural World

We are betting on nature because nature contains the original chemical library.

We are betting on food because the body is built from what we consume.

We are betting on minerals because enzymes, nerves, muscles, hydration, and metabolism depend on them.

We are betting on sunlight because human biology evolved under it.

We are betting on grounding, movement, sleep, and natural cycles because health is not created by one isolated molecule.

We are betting on detoxification because modern people are exposed to industrial chemicals, pollutants, contaminated food, heavy metals, smoke, plastics, and other substances previous generations never faced at this scale.

The Flexner era standardized medical training, but it also narrowed the definition of legitimate medicine. Rockefeller money helped build the centralized institutions that followed. Natural and homeopathic competitors were labeled, excluded, defunded, and pushed outside the mainstream.

That is how institutional control works. It does not require one document titled “The Conspiracy.” It requires concentrated money, aligned institutions, control over education, repeated messaging, professional gatekeeping, and enough time for a manufactured worldview to become accepted as common knowledge.

Modern medicine deserves credit when it saves lives. It deserves relentless scrutiny when it manages preventable illness without confronting why so many people became sick.

The answer is not to return to 1900. The answer is to stop confusing technological intervention with health.

The next system must be transparent, prevention-first, scientifically rigorous, open to nature, hostile to monopoly, and judged by how healthy people become, not by how many prescriptions, procedures, and billable interventions it produces.

Health belongs to the people. Knowledge belongs to the people. Nature belongs to the people.

No corporation, foundation, university, government agency, or billionaire should be permitted to convince us otherwise.

Want to Learn more about the history of food and the chemicals you may be exposed to every day? Go check out Food As a Weapon, the first E-Book in our food freedom series. Check it out here.